These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25873226)

  • 1. [Updated Dementia guideline: reflections from primary care].
    Perry M; Moll van Charante EP
    Ned Tijdschr Geneeskd; 2015; 159():A8939. PubMed ID: 25873226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.
    Wong CW
    Drugs Aging; 2016 Jul; 33(7):451-60. PubMed ID: 27154396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'].
    van Gool WA; Stam CJ; Steenhoek A; Hagemeijer A
    Ned Tijdschr Geneeskd; 2006 Apr; 150(15):839-43. PubMed ID: 16676513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 5. [Role of secondary care too small in Dutch College of General Practitioners' (NHG) practice guideline 'Dementia'].
    Olde Rikkert MG; Lemstra EW; Verhey FR
    Ned Tijdschr Geneeskd; 2012; 156(49):A5554. PubMed ID: 23218040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic guideline and treatment of dementia].
    Olde Rikkert MG; van Exel E; Knol W; Lemstra AW; Roks G; Verhey FR
    Ned Tijdschr Geneeskd; 2015; 159():A8671. PubMed ID: 25873222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Summary of Dutch College of General Practitioners' (NHG) practice guideline 'Dementia'].
    Luning-Koster M; Perry M; Moll van Charante EP; Vernooij-Dassen M; Wiersma T; Burgers JS
    Ned Tijdschr Geneeskd; 2012; 156(49):A5323. PubMed ID: 23218033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
    Buckley JS; Salpeter SR
    Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caregivers' perspectives and experiences of withdrawing acetylcholinesterase inhibitors and memantine in advanced dementia: a qualitative analysis of an online discussion forum.
    Parsons C; Gamble S
    BMC Palliat Care; 2019 Jan; 18(1):6. PubMed ID: 30654782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practice guideline 'Delirium' from the Dutch College of General Practitioners].
    van der Weele GM; Eizenga WH; Dautzenberg PL; Wiersma T; Burgers JS
    Ned Tijdschr Geneeskd; 2014; 158():A7766. PubMed ID: 24975982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.
    van den Bussche H; Kaduszkiewicz H; Koller D; Eisele M; Steinmann S; Glaeske G; Wiese B
    Int Clin Psychopharmacol; 2011 Jul; 26(4):225-31. PubMed ID: 21394033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T; Hommet C; Camus V
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):300-6. PubMed ID: 27651011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Depression in Patients with Dementia: Is Pharmacological Treatment Justified?
    Ford AH; Almeida OP
    Drugs Aging; 2017 Feb; 34(2):89-95. PubMed ID: 28074409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
    Reeve E; Farrell B; Thompson W; Herrmann N; Sketris I; Magin PJ; Chenoweth L; Gorman M; Quirke L; Bethune G; Hilmer SN
    Med J Aust; 2019 Mar; 210(4):174-179. PubMed ID: 30771226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quality of registration of dementia diagnosis in primary care: The situation in Spain in 2002-2011].
    de Hoyos-Alonso Mdel C; Bonis J; Bryant V; Castell Alcalá MV; Otero Puime Á
    Aten Primaria; 2016 Jan; 48(1):33-41. PubMed ID: 26026620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.